Delivery Order HHSN272201500007I-HHSN27200006

Award Date 1/18/18
Potential Completion Date 7/13/23
Potential Value $1.3M
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Hinckley, OH 44233, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $214,395 delivery order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Icon Government And Public Health Solutions, Inc. for Phase 1 clinical trial support services to develop therapeutics against infectious diseases. The award is under the Therapeutics Against Infectious Diseases Phase 1 indefinite delivery/indefinite quantity (IDIQ) contract, which has a potential total value of $1,715,715.70. Icon Government And...
This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Icon Government And Public Health Solutions, Inc. for a Phase I clinical trial unit to support development of therapeutics against infectious diseases. The contract has a potential value of $117,402.00 and is a Cost Plus Fixed Fee contract type. Icon Government And Public Health Solutions, Inc. is a global provider of outsourced...
This is a cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Icon Government And Public Health Solutions, Inc. The $102,610.29 order supports NIAID's Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases program, which conducts early-stage clinical trials of investigational products. The contract is part of a larger $545 million NIAID...
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Icon Government And Public Health Solutions, Inc., a for-profit organization. The $113,678.00 contract is a delivery order under the "Therapeutics Against Infectious Diseases Phase 1" indefinite delivery/indefinite quantity (IDIQ) contract vehicle, which enables streamlined ordering of clinical trial and...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Icon Government And Public Health Solutions, Inc., a global provider of outsourced clinical trial and research services. The $111,477.00 contract is a delivery order under the Therapeutics Against Infectious Diseases Phase 1 indefinite-delivery, indefinite-quantity (IDIQ) master contract, which enables streamlined ordering of clinical...
Icon Government and Public Health Solutions, Inc. was awarded a $119,681 delivery order against the Therapeutics Against Infectious Diseases Phase 1 master indefinite delivery/indefinite quantity contract held with the National Institutes of Health National Institute of Allergy and Infectious Diseases. This delivery order, with a potential value of $48,905.35 and period of performance through February 2024, provides for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases...
This is a task order awarded under the National Institute of Allergy and Infectious Diseases' (NIAID) Early Phase Clinical Trial Units (EPCTU) Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The task order, valued at $2,021,154.00, will support activities defined under Task Area C: Phase I Healthy Volunteer Studies and Task Area D: Phase I Special Population Studies. The contract is a Cost Plus Fixed Fee arrangement and does not utilize any set-aside designations. The prime contractor...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The contract, with a ceiling value of $174,002.53, was awarded to Icon Government And Public Health Solutions, Inc., a for-profit organization, to provide overall administrative and support activities for NIAID's Scientific and Technical Information Coordination and Tracking Group (STI CTG). This includes...
This is a cost-plus-fixed-fee task order awarded to Icon Government and Public Health Solutions, Inc. under the National Institute of Allergy and Infectious Diseases (NIAID) Early Phase Clinical Trial Units (EPCTU) indefinite delivery, indefinite quantity (IDIQ) contract. The task order, valued at $1,628,393.00, will support early phase clinical trials of investigational infectious disease products. Icon, a foreign-owned, for-profit organization, provides comprehensive clinical trial planning...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS), to Icon Government And Public Health Solutions, Inc., a foreign-owned for-profit organization. The $252,853.28 cost-plus-fixed-fee delivery order is for overall administrative and support activities, including procedures to identify, discuss, and develop scientific concepts, for the Scientific and Technical...

This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Icon Government And Public Health Solutions, Inc. The order, valued at $203,215, is for the contractor to provide clinical research management and conduct a Phase 1 clinical trial unit to evaluate therapeutics against infectious diseases. This order is part of a larger 5-year indefinite delivery/indefinite quantity contract vehicle valued at up to $1,315,134.12, which enables streamlined ordering of clinical trials, medical product development, and scientific research services in support of public health and biodefense missions. The contract has no set-aside designation and is expected to be completed by July 13, 2023.

Generated 3/22/24, 9:10 PM